Commerzbank Aktiengesellschaft FI Acquires 23,581 Shares of CVS Health Co. (NYSE:CVS)

Commerzbank Aktiengesellschaft FI grew its holdings in CVS Health Co. (NYSE:CVS) by 29.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 102,991 shares of the pharmacy operator’s stock after buying an additional 23,581 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in CVS Health were worth $4,526,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in CVS. Chicago Partners Investment Group LLC lifted its stake in shares of CVS Health by 5.2% during the 3rd quarter. Chicago Partners Investment Group LLC now owns 13,620 shares of the pharmacy operator’s stock worth $856,000 after buying an additional 676 shares during the last quarter. Van ECK Associates Corp raised its holdings in CVS Health by 17.2% in the 3rd quarter. Van ECK Associates Corp now owns 516,095 shares of the pharmacy operator’s stock valued at $32,452,000 after acquiring an additional 75,805 shares during the period. Cohen Capital Management Inc. boosted its holdings in shares of CVS Health by 0.8% during the third quarter. Cohen Capital Management Inc. now owns 154,797 shares of the pharmacy operator’s stock worth $9,734,000 after acquiring an additional 1,200 shares during the period. National Pension Service grew its position in shares of CVS Health by 17.4% in the third quarter. National Pension Service now owns 2,843,402 shares of the pharmacy operator’s stock valued at $178,793,000 after purchasing an additional 421,416 shares during the last quarter. Finally, Asset Management One Co. Ltd. increased its stake in shares of CVS Health by 9.9% during the third quarter. Asset Management One Co. Ltd. now owns 514,093 shares of the pharmacy operator’s stock worth $32,326,000 after purchasing an additional 46,471 shares during the period. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have commented on CVS. Leerink Partners raised CVS Health from a “market perform” rating to an “outperform” rating and upped their price objective for the company from $55.00 to $75.00 in a report on Thursday, February 13th. Royal Bank of Canada decreased their price target on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research note on Friday, November 15th. Evercore ISI boosted their price objective on shares of CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a report on Monday, January 27th. Truist Financial raised their target price on shares of CVS Health from $60.00 to $76.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Finally, Wells Fargo & Company boosted their price target on CVS Health from $68.00 to $73.00 and gave the company an “overweight” rating in a research note on Thursday, February 13th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $69.83.

Insider Activity at CVS Health

In other CVS Health news, Director Michael F. Mahoney acquired 30,000 shares of CVS Health stock in a transaction that occurred on Tuesday, February 18th. The shares were bought at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the purchase, the director now directly owns 39,356 shares in the company, valued at $2,625,045.20. This trade represents a 320.65 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. 0.24% of the stock is owned by company insiders.

CVS Health Trading Down 1.4 %

Shares of CVS Health stock opened at $64.82 on Tuesday. The firm has a market capitalization of $81.72 billion, a PE ratio of 17.71, a price-to-earnings-growth ratio of 0.98 and a beta of 0.61. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The firm’s 50 day moving average is $54.74 and its 200 day moving average is $56.53. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $80.75.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. Equities research analysts forecast that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.10%. The ex-dividend date was Thursday, January 23rd. CVS Health’s dividend payout ratio is currently 72.68%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.